Possible adverse effect of phenoxybenzamine therapy in a patient with progressive systemic sclerosis
โ Scribed by Dr. Lewis P. Parker; Bevra H. Hahn; C. Kirk Osterland
- Publisher
- John Wiley and Sons
- Year
- 1972
- Tongue
- English
- Weight
- 373 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Although telangiectasias are most commonly found in the skin of progressive systemic sclerosis (PSS) patients, they have also been noted in the gastrointestinal tract (1-7). To our knowledge, telangiectasias in the colon have been described in only 2 PSS patients (5,6). We describe a patient with PS
## Abstract A preliminary study of the fate of radioactive sulfur (Na~2~S^35^O~4~) given intravenously to patients with progressive systemic sclerosis has revealed an appreciably greater radioactivity in the involved skin. The evidence presented suggests an abnormal rate of uptake of sulfur in the
We studied 22 patients with PSS who were treated with riifedipine for more than a year. The mean disease duration was 9.7 f 7.4 years. Digital ulcers were present in 12 patients when therapy was initiated. We wish to emphasize the dramatic beneficial effects of the drug on digital ulcerations; the u